Cargando…
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
BACKGROUND: COVID-19 associated critical illness characterized by rapidly evolving acute respiratory failure (ARF) can develop, especially on the grounds of hyperinflammation. AIM AND METHODS: A case-series of 61 patients admitted to our intensive care unit (ICU) between August 12 and September 12,...
Autores principales: | Mady, Ahmed, Aletreby, Waleed, Abdulrahman, Basheer, Lhmdi, Mohammed, Noor, Alfateh M., Alqahtani, Saleh A., Soliman, Ibrahim, Alharthy, Abdulrahman, Karakitsos, Dimitrios, Memish, Ziad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642808/ https://www.ncbi.nlm.nih.gov/pubmed/33169088 http://dx.doi.org/10.1016/j.amsu.2020.10.061 |
Ejemplares similares
-
Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
por: Mady, Ahmed F., et al.
Publicado: (2023) -
Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives
por: Memish, Ziad A., et al.
Publicado: (2021) -
Helmet Continuous Positive Airway Pressure in the Treatment of COVID-19 Patients with Acute Respiratory Failure could be an Effective Strategy: A Feasibility Study
por: Alharthy, Abdulrahman, et al.
Publicado: (2020) -
Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study
por: Alharthy, Abdulrahman, et al.
Publicado: (2021) -
Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: A prospective observational study
por: Mhawish, Huda, et al.
Publicado: (2021)